iBio
IBIO
#10000
Rank
A$0.11 B
Marketcap
A$1.80
Share price
2.40%
Change (1 day)
46.12%
Change (1 year)

EPS for iBio (IBIO)

EPS in 2026 (TTM): A-$1.17

According to iBio's latest financial reports the company's current EPS (TTM) is A-$1.05. In 2025 the company made an earnings per share (EPS) of A-$2.46 an increase over its 2024 EPS that were of A-$9.12.

EPS history for iBio from 2007 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A-$1.17-52.26%
2025A-$2.46-73.08%
2024A-$9.12-93.88%
2023A-$149.02-8.14%
2022A-$162.2292.67%
2021A-$84.20-80.33%
2020A-$428.01-35.11%
2019A-$659.55-38.96%
2018A-$1,081-6.1%
2017A-$1,15136.67%
2016A-$841.9833.33%
2015A-$631.4950%
2014A-$420.99-53.85%
2013A-$912.15-7.14%
2012A-$982.31-64.1%
2011A-$2,73677.27%
2010A-$1,544144.44%
2009A-$631.4912.93%
2008A-$559.1912.2%
2007A-$498.39

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.26-1,264.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
A-$0.73-30.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
A-$11.82 1,022.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A-$0.24-77.33%๐Ÿ‡บ๐Ÿ‡ธ USA